Phenytoin and Sucralfate drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Phenytoin (phenytoin) and Sucralfate (sucralfate). Common drug interactions include musculoskeletal pain among females and pneumonia among males.

The phase IV clinical study analyzes what interactions people have when they take Phenytoin and Sucralfate. It is created by eHealthMe based on reports of 62 people who take the same drugs from the FDA, and is updated regularly.

What is Phenytoin?

Phenytoin has active ingredients of phenytoin. It is often used in epilepsy. eHealthMe is studying from 15,753 Phenytoin users. Check the latest studies of Phenytoin.

What is Sucralfate?

Sucralfate has active ingredients of sucralfate. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 17,548 Sucralfate users. Check the latest studies of Sucralfate.



On Jul, 15, 2026

62 people who take Phenytoin and Sucralfate together, and have interactions are studied.

Phenytoin and Sucralfate drug interactions.

What are the common drug interactions of Phenytoin and Sucralfate, by gender? *:

female:

  1. Musculoskeletal pain (pain affects the bones, muscles, ligaments, tendons, and nerves)
  2. Nephrogenic systemic fibrosis (involves fibrosis of skin, joints, eyes due to kidney disease)
  3. Neurogenic bladder (the normal function of the bladder is to store and empty urine in a coordinated, controlled fashion)
  4. Oedema (fluid collection in tissue)
  5. Pain
  6. Pain in extremity
  7. Skin fibrosis (fibrous tissue formation on skin)
  8. Skin hyperpigmentation (disorders affect the colour of your skin)
  9. Thrombocytopenia (decrease of platelets in blood)
  10. Weakness

male:

  1. Pneumonia
  2. Febrile neutropenia (fever with reduced white blood cells)
  3. Aspartate aminotransferase increased
  4. Blood lactate dehydrogenase increased
  5. Blood urea increased
  6. Gamma-glutamyltransferase increased
  7. Leukocytosis (increased white blood cells)
  8. Lymphocytosis (an increase in the number or proportion of lymphocytes in the blood)
  9. Rash
  10. Arthralgia (joint pain)

What are the common drug interactions of Phenytoin and Sucralfate, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

  1. Drug level decreased
  2. Nausea (feeling of having an urge to vomit)
  3. Vomiting
  4. Retching (strong involuntary effort to vomit)
  5. Cellulitis orbital (acute spread of infection into the eye socket)
  6. Encephalitis (inflammation of the brain)
  7. Lacunar infarction (a type of stroke)
  8. Malabsorption (a state arising from abnormality in absorption of food nutrients across the gastrointestinal (gi) tract)
  9. Osteonecrosis (death of bone)
  10. Sinusitis fungal (fungal infection of sinus)

20-29:

  1. Fall
  2. Hypoaesthesia (reduced sense of touch or sensation)
  3. Thrombocytopenia (decrease of platelets in blood)
  4. Abnormal behaviour
  5. Agitation (state of anxiety or nervous excitement)
  6. Arthralgia (joint pain)
  7. Blood osmolarity increased
  8. Blood pressure increased
  9. Brief psychotic disorder, without marked stressor(s)
  10. Chest pain

30-39:

  1. Eosinophil count increased
  2. Eosinophil percentage increased
  3. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)
  4. Grand mal convulsion (a type of generalized seizure that affects the entire brain)
  5. Haematoma (collection of blood outside the blood vessels)
  6. Haemoglobin decreased
  7. Ingrowing nail
  8. Myoclonic jerks (involuntary twitching of a muscle or group of muscles)
  9. Oxygen saturation decreased
  10. Pleurisy (inflammation of the pleurae, which causes pain when breathing)

40-49:

  1. Arrhythmia (irregular heartbeat)
  2. Bezoar (mass found trapped in the gastrointestinal system)
  3. Chronic kidney disease
  4. Coma (state of unconsciousness lasting more than six hours)
  5. Food interaction
  6. Oesophageal obstruction (blockage of oesophagus)
  7. Renal failure (kidney dysfunction)
  8. Urine discolouration

50-59:

  1. Anaemia (lack of blood)
  2. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  3. Anxiety
  4. Chronic kidney disease
  5. Decreased activity
  6. Depression
  7. Emotional distress
  8. Fatigue (feeling of tiredness)
  9. Fear
  10. Gastrointestinal haemorrhage (bleeding gastrointestinal tract)

60+:

  1. Blister (small pocket of fluid within the upper layers of the skin caused by forceful rubbing (friction), burning, freezing, chemical exposure)
  2. Mucosal erosion (peeling off of mucous membrane)
  3. Lymphocytosis (an increase in the number or proportion of lymphocytes in the blood)
  4. Pyrexia (fever)
  5. Rash
  6. Febrile neutropenia (fever with reduced white blood cells)
  7. Stevens-johnson syndrome (an immune-complex-mediated hypersensitivity disorder. it ranges from mild skin and mucous membrane lesions to a severe)
  8. Toxic epidermal necrolysis (a rare, life-threatening skin condition that is usually caused by a reaction to drugs causes wide spread skin destruction)
  9. Constipation
  10. Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)

What are the existing conditions these people have? *

  1. Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 8 people, 12.90%
  2. Pain: 5 people, 8.06%
  3. Infection: 5 people, 8.06%
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body): 5 people, 8.06%
  5. Nuclear Magnetic Resonance Imaging Brain: 4 people, 6.45%
  6. Mucormycosis (a rare infection caused by organisms that belong to a group of fungi called mucoromycotina): 4 people, 6.45%
  7. Hypersensitivity: 4 people, 6.45%
  8. Cough: 4 people, 6.45%

* Approximation only. Some reports may have incomplete information.

Do you take Phenytoin and Sucralfate?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Phenytoin and Sucralfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Phenytoin:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Sucralfate:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Phenytoin and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sucralfate and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Related publications that referenced our studies

  • Wandalkar P, Daswani BR, Pandit PT, Ghongane BB, "A case of Phenytoin toxicity", INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY, 2014 Jan .
  • Wandalkar P, Daswani BR, Pandit PT, Ghongane BB, "A case of Phenytoin toxicity", INTERNATIONAL JOURNAL OF ADVANCES IN PHARMACY, BIOLOGY AND CHEMISTRY, 2014 Jan .

How the study uses the data?

The study uses data from the FDA. It is based on phenytoin and sucralfate (the active ingredients of Phenytoin and Sucralfate, respectively), and Phenytoin and Sucralfate (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: